精准医学的新希望。
A new hope for precision medicine.
机构信息
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.
出版信息
Sci Transl Med. 2013 Oct 23;5(208):208fs38. doi: 10.1126/scitranslmed.3007622.
PMID:24154598
Abstract
The SS1P immunotoxin is combined with immunomodulatory therapy in order to improve its efficacy in human mesothelioma (Hassan et al., this issue).
摘要
SS1P 免疫毒素与免疫调节疗法相结合，以提高其在人类间皮瘤中的疗效（Hassan 等人，本期）。
相似文献
1
A new hope for precision medicine.精准医学的新希望。
Sci Transl Med. 2013 Oct 23;5(208):208fs38. doi: 10.1126/scitranslmed.3007622.
2
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.间皮瘤在用抗间皮素免疫毒素和免疫抑制治疗后出现主要肿瘤消退。
Sci Transl Med. 2013 Oct 23;5(208):208ra147. doi: 10.1126/scitranslmed.3006941.
3
Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P.持续输注抗间皮素重组免疫毒素SS1P的I期试验。
Clin Cancer Res. 2009 Aug 15;15(16):5274-9. doi: 10.1158/1078-0432.CCR-09-0062. Epub 2009 Aug 11.
4
5
New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma.新型高亲和力单克隆抗体可识别间皮素上不重叠的表位，用于监测和治疗间皮瘤。
Sci Rep. 2015 May 21;5:9928. doi: 10.1038/srep09928.
6
7
Treatment of peritoneal mesothelioma.腹膜间皮瘤的治疗
Arch Surg. 1989 Feb;124(2):256. doi: 10.1001/archsurg.1989.01410020130023.
8
[Considerable rise in CA 125 antigen level during mesothelioma].[间皮瘤期间CA 125抗原水平显著升高]
Presse Med. 1990 Oct 6;19(32):1503.
9
Current management strategies for peritoneal mesothelioma.腹膜间皮瘤的当前治疗策略。
Int J Hyperthermia. 2017 Aug;33(5):579-581. doi: 10.1080/02656736.2017.1320591.
10
[Peritoneal mesothelioma].[腹膜间皮瘤]
Dtsch Med Wochenschr. 1980 Apr 18;105(16):549.
Zotero 插件